Skip to main content

GOLDMAN SACHS GROUP INC

Position in FENC — Fennec Pharmaceuticals Inc.

CIK 886982 NEW YORK, NY

Position in FENC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$359,609
+$17,277 QoQ
Shares Held
33,452
-39.9% QoQ
Ownership
0.095%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 104 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FENC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. FENC ranks #300 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FENC

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $359,609 33,452
2026-03-31 $342,332 55,664
2025-12-31 $335,635 43,589
2025-09-30 $247,946 26,490
2025-06-30 $132,285 15,938
2025-03-31 $263,209 43,220
2024-12-31 $449,965 71,197
2024-09-30 $268,765 53,753
2024-06-30 $123,018 20,134
2024-03-31 $479,171 43,091
2023-12-31 $347,820 31,000
2023-09-30 $130,193 17,336
2023-06-30 $272,246 30,832
2023-03-31 $172,648 20,751
2022-12-31 $201,456 20,985
2022-06-30 $55,961 10,029
2022-03-31 $73,248 13,080
2021-12-31 $59,171 13,448
2021-09-30 $126,529 13,432
2021-06-30 $97,671 13,398
2021-03-31 $130,763 21,057
2020-12-31 $183,798 24,671
2020-09-30 $150,288 24,800
2020-06-30 $255,184 30,561
2020-03-31 $84,490 14,224